Literature DB >> 8630993

Retinoic acid metabolism and inhibition of cell proliferation: an unexpected liaison.

J Takatsuka1, N Takahashi, L M de Luca.   

Abstract

The rationale for the use of all-trans-retinoic acid (RA) as an anticancer agent is based on its ability to inhibit growth and promote differentiation of some neoplastic cells. However, RA is not effective in all conditions of cell culture, and in some cases, it may stimulate cell growth. We used a serum-free culture system to study the effect of RA on cell proliferation. Following 2 days of RA exposure, 9 of a total of 15 cell lines showed an inhibition of cell growth (RA-sensitive), while 6 of 15 cell lines showed resistance to RA (RA-resistant cells). Metabolic studies and high-performance liquid chromatography analysis of the cell-associated and medium extracts from cells incubated with [3H]RA revealed that all nine RA-sensitive cells showed a very high activity to metabolize RA to polar metabolites found in the medium. In sharp contrast, RA-resistant cells retained about 60% of the original RA at 76 h. However, conditioned medium from the sensitive cells was without activity on the growth of sensitive and resistant cells. We conclude that a relationship exists between RA inhibition of cell growth and intracellular RA metabolism. These data may help design useful strategies in cancer therapy by retinoids and dispel the notion that RA itself is responsible for the inhibition of cell growth.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630993

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Inhibition of retinol oxidation by ethanol in the rat liver and colon.

Authors:  A Parlesak; I Menzl; A Feuchter; J C Bode; C Bode
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  All-trans-retinoic acid distribution and metabolism in vitamin A-marginal rats.

Authors:  Christopher J Cifelli; A Catharine Ross
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-08       Impact factor: 4.052

3.  Retinoic acid combined with vitamin A synergizes to increase retinyl ester storage in the lungs of newborn and dexamethasone-treated neonatal rats.

Authors:  A Catharine Ross; Namasivayam Ambalavanan
Journal:  Neonatology       Date:  2007-02-23       Impact factor: 4.035

4.  Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.

Authors:  Shunsuke Sato; Takuya Genda; Katsuharu Hirano; Hironori Tsuzura; Yutaka Narita; Yoshio Kanemitsu; Tetsu Kikuchi; Katsuyori Iijima; Ryo Wada; Takafumi Ichida
Journal:  Liver Int       Date:  2012-06-11       Impact factor: 5.828

5.  Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines.

Authors:  B J Braakhuis; I Klaassen; B M van der Leede; J Cloos; R H Brakenhoff; M P Copper; T Teerlink; H F Hendriks; P T van der Saag; G B Snow
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  All-trans-retinoic acid metabolites significantly inhibit the proliferation of MCF-7 human breast cancer cells in vitro.

Authors:  J Van heusden; W Wouters; F C Ramaekers; M D Krekels; L Dillen; M Borgers; G Smets
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

7.  CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.

Authors:  Rong-Zong Liu; Elizabeth Garcia; Darryl D Glubrecht; Ho Yin Poon; John R Mackey; Roseline Godbout
Journal:  Mol Cancer       Date:  2015-07-05       Impact factor: 27.401

8.  High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.

Authors:  Yan-Yan Wang; Lu-Nan Qi; Jian-Hong Zhong; Hong-Gui Qin; Jia-Zhou Ye; Shi-Dong Lu; Liang Ma; Bang-De Xiang; Le-Qun Li; Xue-Mei You
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

9.  Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis.

Authors:  Hironori Tsuzura; Takuya Genda; Shunsuke Sato; Ayato Murata; Yoshio Kanemitsu; Yutaka Narita; Sachiko Ishikawa; Tetsu Kikuchi; Masashi Mori; Katsuharu Hirano; Katsuyori Iijima; Ryo Wada; Takafumi Ichida
Journal:  Int J Mol Sci       Date:  2014-04-17       Impact factor: 5.923

10.  DNA Methylation Predicts the Response of Triple-Negative Breast Cancers to All-Trans Retinoic Acid.

Authors:  Krysta Mila Coyle; Cheryl A Dean; Margaret Lois Thomas; Dejan Vidovic; Carman A Giacomantonio; Lucy Helyer; Paola Marcato
Journal:  Cancers (Basel)       Date:  2018-10-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.